47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.11.Z - Non-specialized retail trade with a predominance of food, beverages, or tobacco products
47.25.Z - Retail trade of alcoholic and non-alcoholic beverages
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,1 | 0,1 | 0,1 | -32,9 |
Gross profit (loss) | 0,1 | 0,1 | 0,1 | -32,7 |
EBITDA | 0,1 | 0,2 | 0,1 | -9,3 |
Short time liabilities | 0,1 | 0,2 | 0,2 | 3,8 |
Other operating costs | 0 | 0 | 0 | 29 040 |
Equity capital | 0,5 | 0,6 | 0,7 | 12,5 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,1 | -31,9 |
Assets | 0,6 | 0,7 | 0,8 | 10,6 |
Net profit (loss) | 0,1 | 0,1 | 0,1 | -33,3 |
Cash | 0,4 | 0,4 | 0,5 | 22,9 |
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,2 | 3,8 |
Net income from sale | 1,9 | 2,1 | 2,2 | 2,9 |
Working assets | 0,6 | 0,6 | 0,7 | 23,4 |
Other income costs | 0 | 0 | 0 | 57,7 |
Depreciation | 0 | 0 | 0,1 | 79,3 |
% | % | % | p.p. | |
Profitability of capital | 17,7 | 18,8 | 11,1 | -7,7 |
Equity capital to total assets | 77,1 | 77,7 | 79 | 1,3 |
Gross profit margin | 5 | 5,7 | 3,8 | -1,9 |
EBITDA Margin | 6,4 | 7,2 | 6,4 | -0,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 28 | 29 | 29 | 0 |
Current financial liquidity indicator | 3.9455010890960693 | 3.437211275100708 | 4.085546493530273 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane